Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark
June 29, 2015 at 07:46 AM EDT
In a report published Monday, Leerink analyst Seamus Fernandez downgraded the rating on Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) ...